Showing all 4 results
Neostigmine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the highly hygroscopic bromide salt.
Active Ingredient Strength Primary Clinical Function Neostigmine Bromide Ph.Eur./USP 15 mg Global Clinical Standard: Base therapeutic oral unit for the continuous, meticulously spaced symptomatic management of Myasthenia Gravis. Excipients Lactose Monohydrate / Maize Starch / Povidone K30 / Talc / Magnesium Stearate Diluent / Binder / Glidant / Lubricant (Engineered specifically for rapid, predictable gastric dissolution to ensure precise symptom control within 30 to 45 minutes of ingestion) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict, high-volume chronic neurology dispensing, as patients may require up to 10-15 tablets per day in divided doses).
Thiocolchicoside Tablet
FreeThiocolchicoside tablets primarily contain Thiocolchicoside as the active pharmaceutical ingredient. It is a centrally acting muscle relaxant used to treat painful muscle spasms and stiffness associated with spinal, orthopedic, and neurological conditions.
Tizanidine Tablet 2mg
FreeTizanidine 2 mg tablets contain 2 mg of tizanidine (present as approximately 2.29 mg of tizanidine hydrochloride) as the active pharmaceutical ingredient. It is a centrally acting skeletal muscle relaxant used to manage muscle spasticity and spasms.
Tolperisone 150 mg Tablet
FreeTolperisone 150 mg tablets contain 150 mg of Tolperisone Hydrochloride as the active pharmaceutical ingredient. It is a centrally acting muscle relaxant used to treat muscle spasms, stiffness, and increased muscle tone associated with various neurological and musculoskeletal conditions
